Skip to main content

June 2021

 

 

academics

 

Clinical research courses

Strides partnered with Ennaid for AI based COVID-19 medicine

Strides Pharma Science Limited announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has entered into an exclusive partnership with Ennaid Therapeutics, a global pharmaceutical company to produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19.

Multiple Job openings at Institute of Himalayan Bioresource Technology - M.Pharm, M.Sc apply

CSIR-IHBT is one of the 38 national laboratories of the Council of Scientific Industrial Research. It is located in the backdrop of snow-covered peaks of Dhauladhar mountain range at an elevation of 1300 m amsl. The Institute has a focus to develop technologies for boosting bioeconomy through sustainable utilization of Himalayan bioresources for societal, industrial and environmental benefits.

INDIAN ARMY PHARMACIST RECRUITMENT

The Indian Army promises both professional and personal growth at every stage of the career. Opportunities to excel through various courses are abundant including opportunities to enhance your educational qualification by availing two years paid study leave. The inherent adventure and extra-curricular activities in the Army ensure an all round development essential in todays world. Art of War Engineering Medicine Administration Human Resource Development and Management; the army teaches you all.

Job for Pharmacy graduates at KAPL - Government of India Enterprise | 22 vacancies

Karnataka Antibiotics and Pharmaceuticals Limited, KAPL Bengaluru is a Government of India Enterprise.  Karnataka Antibiotics and Pharmaceuticals Limited is a Joint Sector Company of Government of India with shareholding from Government of Karnataka through Karnataka State Industrial Infrastructure Development Corporation KSIIDC. From a modest beginning in 1984, KAPL has grown exponentially in the areas of manufacturing and marketing of various life saving and essential drugs.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Production, QA at Vital Pharma

Vital Therapeutics and Formulations Private Limited is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes.

Job for M.Pharm, B.Pharm, M.Sc in QA, QC, Production, Regulatory Affairs at Bharat Parenterals Ltd

Bharat Parenterals Ltd. is a Gujarat based pharmaceutical company, established in 1992 by Mr. Ramesh Desai, who started the company with a vision of making world class affordable medicines and to take it to the forefront of contract manufacturing units in Gujarat. Under the chairmanship of Mr.

Quality Assurance Executive Job at Piramal Healthcare Limited | M.Pharm, B.Pharm apply

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Executive - Quality Assurance - (210001EQ)

Vacancy for M.Pharm, B.Pharm, M.Sc in Production, EHS, Regulatory Affairs, QC, IPQA at Nanz Medscience Pharma Ltd

Nanz Medscience Pharma Ltd. is a global wellness and healthcare company, a Subsidiary of Med Science Canada Inc. Nanz Medscience is a multidimensional company manufacturing pharmaceutical external formulations, cosmetic products, wellness products, swabs, diagnostic kits and trading of specialty chemicals. Under the aegis of the chairman of the chairman Mr. LP Singh, Nanz Medscience is a torch bearer of responsible business ethos. Driven by creativity and innovation of the M.D. Mr.

AICTE Training and Learning Academy Sponsored Online Faculty Development Program

About Utkal University

Novavax COVID-19 Vaccine 90% efficacy in Phase 3 Trial

Novavax, Inc announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. The study enrolled 29,960 participants across 119 sites in the U.S. and Mexico to evaluate efficacy, safety and immunogenicity, with an emphasis on recruiting a representative population of communities and demographic groups most impacted by the disease.